The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Kornoukhova L.A.

North-Western Centre of Evidence-based Medicine Co., Saint Petersburg, Russia;
Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First Saint Petersburg State Medical University» of the Ministry of Healthcare of the Russia, Saint Petersburg, Russia

Emanuel’ V.L.

Federal State Budgetary Educational Institution of Higher Education «Academician I.P. Pavlov First Saint Petersburg State Medical University» of the Ministry of Healthcare of the Russia, Saint Petersburg, Russia

Denisov N.L.

N.I.Pirogov Clinic of High Medical Technologies of the Saint-Petersburg State University

The role of the laboratory evaluation of the liver for detection of obesity

Authors:

Kornoukhova L.A., Emanuel’ V.L., Denisov N.L.

More about the authors

Read: 1588 times


To cite this article:

Kornoukhova LA, Emanuel’ VL, Denisov NL. The role of the laboratory evaluation of the liver for detection of obesity. Russian Journal of Evidence-Based Gastroenterology. 2018;7(2):10‑16. (In Russ.)
https://doi.org/10.17116/dokgastro20187210

Recommended articles:
Biomarkers of aging mechanisms. Problems of Balneology, Physiotherapy and Exercise Therapy. 2025;(5-2):108-119
Analysis of the family medi­cine centers acti­vity in the Osh region and the Osh city. Russian Journal of Preventive Medi­cine. 2026;(2):13-19

References:

  1. EASL-EASD-EASO. Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease. Journal of Hepatology. 2016;64(6):1388-1402. https://doi.org/10.1016/j.jhep.2015.11.004
  2. Zhou J, Li ML, Zhang DD, Lin HY, Dai XH, Sun XL, Li JT, Song LY, Peng H, Wen MM. The correlation between pancreatic steatosis and metabolic syndrome in a Chinese population. Pancreatology. 2016;16(4):578-583. Available at: http://www.ncbi.nlm.nih.gov/pubmed/27050733. Accessed Jule, 23, 2016. https://doi.org/10.1016/j.pan.2016.03.008
  3. Utzschneider KM, Kahn SE. Review: the role of insulin resistance in nonalcoholic fatty liver disease. J Clin Endocrinol Metab. 2009;91(12):4753-4761. https://doi.org/10.1210/jc.2006-0587
  4. Titov VN.The functional difference between visceral fatty cells and subcutaneous adipocytes. Klin med. 2015;93(2):14-23. (In Russ.)
  5. Garvey WT, Mechanick JI, Brett EM, Garber AJ, Hurley DL, Jastreboff AM, Nadolsky K, Pollack P, Plodkowski R. Reviewers of the AACE/ACE Obesity Clinical Practice Guidelines. Endocr Pract. 2016;22(3):1-203. https://doi.org/10.4158/ep161365.gl
  6. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart J-C, James WT, Loria CM, Smith SC. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the study of Obesity. Circulation. 2009;120:1640-1645. https://doi.org/10.1161/circulationaha.109.192644
  7. Chumakova GA, Veselovskaya NG, Gritsenko OV, Ott AV. Metabolic syndrome: challenging and unresolved issues. Russ J Cardiol. 2014;3(107):63-71. (In Russ.)
  8. Amato MC, Giordano C, Galia M, Criscimanna A, Vitabile S. Visceral adiposity index: a reliable indicator of visceral fat function associated with cardiometabolic risk. Diabetes Care. 2010;33:920-922. https://doi.org/10.233/dc09-1825
  9. Rekomendatsii po vedeniyu bol’nykh s metabolicheskim sindromom (Natsional’nye kli-nicheskie rekomendatsii). M: Ministerstvo zdravookhraneniya RF, 2013. (In Russ.)
  10. Shlyakhto EV, Nedogoda SV, Konradi АО, Baranova EI, Fomin VV, Vertkin АL, Chumakova GА. The concept of novel national clinical guidelines on obsety. Russ J Cardiol. 2016;4(132):7-13. (In Russ.) https://doi.org/10.15829/1560-4071-2016-4
  11. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA. 2001;285:2486-2497. https://doi.org/10.1001/jama.285.19.2486
  12. ESC/EAS Guidelines for the Management (2016). The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). European Heart Journal. 2016;37:2999-3058. https://doi.org/10.1093/eurheartj/ehw272
  13. Amato MC, Giordano C, Pitrone M, Galluzzo A. Cut-off points of the visceral adiposity index (VAI) identifying a visceral adipose dysfunction associated with cardiometabolic risk in a Caucasian Sicilian. Lipids in Health and Disease. 2011;10(183):1-8. https://doi.org/10.1186/1476-511X-10-183
  14. Drapkina OM, Yafarova AA. Non-alcoholic fatty liver disease and cardiovascular risk: scientific problem state. Rational Pharmacotherapy in Cardiology 2017;13(5):645-650. (In Russ.) https://doi.org/10.20996/1819-6446-2017-13-5-645-650

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.